Renal Medullary Carcinoma: Case Report of an Aggressive Malignancy with Near-Complete Response to Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy

Benzer Materyaller

• Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates
  Yazar:: Choueiri, Toni K., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis
  Yazar:: Chung, Doo Yong, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Comment on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: Results of the GETUG-AFU V05 VESPER trial
  Yazar:: Jian-Jun Ye, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-02-01)
• Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysis
  Yazar:: Karadimou, Alexandra, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy
  Yazar:: Han, K S, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)